OTCMarketbulls.com Brings You the HOTTEST gainers! SVN +10.52%, PNX +8.21%, TGB +9.60%, CTT +23.53%

OTCMarketbulls.com Presents: 7 Days Group Holdings Limited (NYSE: SVN), The Phoenix Companies (NYSE: PNX), Taseko Mines Limited (AMEX: TGB), Competitive Technologies (AMEX: CTT)

To sign up for our free Profiles & Alerts :: visit http://www.otcmarketbulls.com

Also find out daily volume movers on twitter: www.twitter.com/otcmarketbulls

------------------------------------------------------------------------------------------------------------------------------------------------------------

SVN LATEST NEWS

7 Days Group to Attend the Oppenheimer China Dragon Call Conference GUANGZHOU, China, May 12 -- 7 Days Group Holdings Limited ("7 Days Group" or the "Company") (NYSE:SVN - News), a leading economy hotel chain based in China, announced today it will attend the Oppenheimer China Dragon Call Conference to be held on May 18-20, 2010 at the Oppenheimer Executive Conference Center in New York, NY.

Mr. Eric Wu, 7 Days Group Chief Financial Officer is scheduled to present on Wednesday, May 19, 2010 at 9:05 am Eastern Time, and will be available to meet with analysts and investors.

For further information, including presentations for download, please visit the investor relations page of the Company's website at http://en.7daysinn.cn/ .

About 7 Days Group Holdings Limited

7 Days Group is a leading and fast growing national economy hotel chain based in China. It converts and operates limited service economy hotels across major metropolitan areas in China under its award-winning "7 Days Inn" brand. The Company strives to offer consistent and high-quality accommodations and services primarily to the growing population of value-conscious business and leisure travelers who demand affordable, clean, comfortable, convenient and safe lodging, and to respond to its guests' needs.

------------------------------------------------------------------------------------------------------------------------------------------------------------

PNX LATEST NEWS

The Phoenix Companies, Inc. Historic Headquarters Building Recognized for Environmental Excellence HARTFORD, Conn.--(5/12/10)--The Phoenix Companies, Inc. today announced that its landmark One American Row building, located in Hartford, Connecticut, has been awarded Silver-level LEED certification for existing buildings (LEED-EB) by the U.S. Green Building Council.

It is the first office building to receive LEED-EB Silver certification in the City of Hartford and only the second office building to receive certification in the state of Connecticut. In addition, One American Row becomes the first office building in New England, and one of the few in the United States, that is both on the National Register of Historic Places and LEED-EB certified.

The locally dubbed "boat building" opened in 1963 and is prized as a stellar example of the Modernist architectural style, with its unique form and two-sided lenticular plan. It was added to the National Register of Historic Places in 2005. Managed by the National Park Service, the National Register of Historic Places is the nation's official list of historical resources worthy of preservation.

The U.S. Green Building Council's LEED (Leadership in Energy and Environmental Design) Green Building Rating System is a voluntary third-party rating system where credits are earned for satisfying specified green building criteria. Projects are evaluated within five environmental categories, including Sustainable Sites, Water Efficiency, Energy and Atmosphere, Materials and Resources, and Indoor Environmental Quality, with additional points available for innovations.

Certified, Silver, Gold and Platinum levels of certification are awarded based on the total credits earned. With an ENERGY STAR rating of 89, One American Row garnered 12 out of a possible 15 LEED points for Optimizing Energy Efficiency Performance, with the Green Cleaning program obtaining 7 out of a possible 9 LEED points. Overall, One American Row came within 5 points of obtaining Gold certification.

About Phoenix

Dating to 1851, The Phoenix Companies, Inc. (NYSE:PNX - News) provides financial solutions using life insurance and annuities. In 2009, Phoenix had annual revenues of $2.1 billion and total assets of $24.6 billion at year end. For more information, visit http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.phoenixwm.com%2F&esheet=6287144&lan=en_US&anchor=www.phoenixwm.com&index=1&md5=c49c6b453491c4e06f2025054ba97fa1.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6287144&lang=en

MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6287144

------------------------------------------------------------------------------------------------------------------------------------------------------------

TGB LATEST NEWS

Taseko Signs Gold Stream Agreement with Franco-Nevada for 22% of Future Gold Production from Prosperity for US$350 Million Plus Franco-Nevada Warrants VANCOUVER, May 12 - Taseko Mines Limited (TSX: TKO; NYSE Amex: TGB) ("Taseko" or the "Company") announces it has entered into a gold stream transaction with Franco-Nevada Corporation (TSX:FNV.to - News) ("Franco-Nevada"), under which Franco-Nevada will purchase gold equal to 22% of the life of mine gold to be produced by Taseko from its proposed Prosperity Gold and Copper Mine ("Prosperity") in British Columbia (the "Transaction").

Taseko will receive staged cash deposits in aggregating US$350 million to be paid during mine construction as well as 2 million Franco-Nevada warrants to be issued on the date of the first advance of the cash payment. For each ounce of gold delivered to Franco-Nevada, Taseko will receive a further cash payment of US$400 (subject to an inflationary adjustment) or the prevailing market price, if lower. The deposit will be credited with the difference between US$400 and the market price of gold for each ounce delivered until the deposit is fully credited. Each warrant will be exercisable to purchase one Franco-Nevada common share at a price of $75.00 until June 16, 2017 and will be listed under the same terms as the warrants listed on TSX under the symbol FNV.WT.A.

The investment by Franco-Nevada is subject to full financing of the project and receipt of all material permits to construct and operate the Prosperity project and will be staged such that the timing of Franco-Nevada's payments will be concurrent with Taseko's funding of the equity portion of the capital requirements of Prosperity.

Russell Hallbauer, President and CEO of Taseko, commented "We are very pleased to be entering into this long-term relationship with Franco-Nevada. It is an endorsement of the quality of our project that we have been able to attract the interest of a company of the calibre of Franco Nevada as a participant in the advancement of Prosperity. Through this transaction, we are funding approximately 45% of the planned capital expenditures for Prosperity by selling 6% of the total gross metal revenue. Combined with cash on hand and expected cash flow from Gibraltar, we will have Prosperity approximately 80% funded without any debt, leaving a number of available alternatives to complete the project funding. These include project debt, equity, off-take sale for debt and the sale of a small minority interest in Prosperity."

Wellington West Capital Markets Inc. is acting as financial advisor to Taseko.

Prosperity

Taseko holds a 100% interest in the Prosperity property, located 125 kilometers southwest of the City of Williams Lake. The property hosts a large porphyry gold-copper deposit amenable to open pit mining. Proven and probable mineral reserves are 830 million tonnes grading 0.41 g/t gold and 0.23% copper, with recoverable metal of 7.7 million ounces of gold and 3.6 billion pounds of copper(1), which under the present mine design criteria represents a mine life of 33 years. It is anticipated the Prosperity project could be commissioned by 2013, subject to timely permitting and construction. On January 14, 2010, Taseko received the environmental assessment certificate for the project from the British Columbia Provincial Ministry of Environment. This is an important milestone as it is the provincial government which is responsible for mine development in British Columbia.

The federal process, conducted by a three-person Panel operating under defined Terms of Reference, is required to complete their work in a timely and efficient manner. The hearings commenced in late March and were completed on May 3, 2010. Following conclusion of the hearings, the Panel will submit their findings to the Federal Minister of Environment for a decision. This process is expected to complete by the third quarter of 2010.

Russell Hallbauer President and CEO

Note 1 - Mineral Reserves at a C$5.50 Net Smelter Return/tonne cut-off. Recoveries for gold and copper are 69% and 87%, respectively.

No regulatory authority has approved or disapproved of the information contained in this news release.

------------------------------------------------------------------------------------------------------------------------------------------------------------

CTT LATEST NEWS

Doctors at Boston Medical Symposium Will Present Evidence-Based Patient Treatment Successes With Calmare(R) Pain Therapy Innovative, Non-Invasive Pain Treatment From Competitive Technologies Has Been Used Extensively in Europe -- Now at U.S. Teaching Hospitals and Pain Clinics FAIRFIELD, Conn., May 13, 2010-- Competitive Technologies, Inc. (NYSE Amex:CTT) will showcase its Calmare(R) Pain Therapy Treatment at a symposium for medical professionals in Boston, Mass., on May 17, 2010. Several noted physicians will describe their successful experiences among patients suffering from chronic pain associated with cancer and various types of neuropathic conditions. Medical professionals who wish to attend the conference should contact Kim Thompson at 203.331.4817 or [email protected], to ensure adequate space is available on Monday.

The keynote speaker will be Calmare's inventor, Professor Giuseppe Marineo, MD, DSc., Researcher, Founding President of Delta Research and Development, Tor Vergata University of Rome, Italy. Prof. Marineo will present his "Scrambler Therapy," the technology and scientific basis for this revolutionary pain treatment method. Throughout the day, physicians from the Boston Foundation for Sight, the University of Miami, the University of Wisconsin, and Calmar Pain Relief, LLC, will present evidence-based patient case studies developed from their use of this innovative technology to treat various types of chronic pain from cancer and chemotherapy-induced peripheral neuropathy (CIPN), failed back surgery, phantom limb syndrome, as well as pain from shingles, sciatica and a variety of other maladies. Typically, the patients' pain has been resistant to other treatment methodologies, including powerful narcotic painkillers, with associated adverse side effects.

The physicians presenting their evidence-based patient experiences include:

Perry Rosenthal, MD - Founding President, Vice Chairman and Scientific Director at the Boston Foundation for Sight, and Assistant Clinical Professor of Ophthalmology, Harvard Medical School Salahadin Abdi, MD - Professor and Chief, University of Miami Pain Center, Anesthesiology, Perioperative Medicine & Pain Management Toby Campbell, MD - Assistant Professor of Medicine, Hematology & Oncology, University of Wisconsin, Paul J. Carbone Cancer Center Stephen J. D'Amato, MD, FACEP- Medical Director, Calmar Pain Relief, LLC; Clinical Assistant Professor of Medicine, Boston University School of Medicine, and Medical Staff, Roger Williams Medical Center.

"We are privileged and pleased to have these doctors attest to the effectiveness of our Calmare pain therapy treatment by sharing evidence-based patient successes with other physicians attending our symposium," said John B. Nano, CTT's Chairman, President and CEO. "We are fortunate that on his first U.S visit, Prof. Marineo has taken the time to discuss this innovative technology. I know he will provide a unique perspective for physicians desiring a scientific understanding of the device and its efficacy in relieving patients' pain. Gaining greater knowledge of how the Calmare treatment works will prove very helpful to doctors and other medical professionals."

"With recent media coverage focusing on the negative side effects of morphine and other powerful opioid painkillers, the Calmare therapy offers physicians an effective alternative for treating high intensity oncologic and neuropathic pain, including pain resistant to opioids and other treatment methodologies," Mr. Nano continued. "The Calmare Pain Therapy Treatment, with U.S. FDA clearance and European Union CE Certification for sales, is a prime example of CTT's strategy to connect clinical science to patient care."

For more information about Calmare pain therapy, visit: http://www.CalmareTT.com/. Additional details about the conference can be found at www.competitivetech.net/events/tradeshows.html.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTT is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: http://www.globenewswire.com/newsroom/ctr?d=191763&l=8&a=www.competitivetech.net&u=http%3A%2F%2Fwww.competitivetech.net.

------------------------------------------------------------------------------------------------------------------------------------------------------------

OTCMarketbulls.com is an online financial destination where money managers, analysts, and individual investors can converge to discover new and exciting investment news, opportunities, and ideas. OTCMarketBulls.com is focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by OTCMarketBulls.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.

For full disclaimer/disclosure: http://www.otcmarketbulls.com/disclaimer.php

Visit Us On Twitter and Facebook: http://twitter.com/otcmarketbulls http://www.facebook.com/otcmarketbulls

((Comments on this story may be sent to [email protected]))